Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Roma
Clinical trial register · Italy

Clinical Trials in Roma, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 2846 Bologna 1303 Roma 1272 Naples 983 Rome 968
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS197 AstraZeneca71 Novartis Pharmaceuticals52 Janssen Research & Development, LLC44 Merck Sharp & Dohme LLC43
Site location
Milan2846 Bologna1303 Roma1272 Naples983 Rome968
All 489 locations
Target enrolment
to

Trials with a site in Roma

1272 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
By invitation
QED Therapeutics, a BridgeBio company
Phase 2
300
Milan, Roma
2021-12-06
Active, closed
Abivax S.A.
Phase 2
203
Roma, Rozzano, Verona
2021-12-03
Recruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not applicable
48
Roma
2021-11-25
Recruiting
SEBBIN Round, Anatomical and Biconvex Gluteal Implants
NCT05062733Complication, Prosthesis Durability
Groupe SEBBIN
Observational
60
Roma
2021-11-20
Active, closed
AstraZeneca
Phase 3
145
Milan, Naples, Roma
2021-11-19
Active, closed
Gilead Sciences
Phase 3
603
Bergamo, Brescia, Catania, Catanzaro, Cremona, Milan, Pavia, Roma
2021-11-17
Recruiting
Prevalence of Latent Tuberculosis Infection in Health-care Workers and Students
NCT05756582Tuberculosis, Tuberculosis, Pulmonary, Tuberculosis Infection, Latent Tuberculosis
Eleonora Nucera
Observational
2,040
Roma
2021-11-17
Recruiting
Pfizer
Phase 3
245
Genoa, Rozzano, Roma, Milan
2021-11-17
Active, closed
AbbVie
Observational
873
Bari, Catania, Genoa, Messina, Milan, Turin, Roma, Cava de' Tirreni
2021-11-17
Active, closed
Janssen Research & Development, LLC
Phase 3
776
Aviano, Meldola, Milan, Parma, Ravenna, Roma, Verona
2021-11-17
Active, closed
Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II
NCT04893291Coronary Artery Disease, Coronary Artery Stenosis
Fondazione Ricerca e Innovazione Cardiovascolare ETS
Not applicable
1,820
Aversa, Brescia, Genova, La Spezia, Milan, Paderno Dugnano, Palermo, Roma
2021-11-16
Recruiting
Leiden University Medical Center
Phase 3
316
Roma
2021-11-11
Recruiting
Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma
NCT04383119Leiomyosarcoma of Ovary, Soft Tissue Sarcoma
DrugsTrabectedin·Gemcitabine
Italian Sarcoma Group
Phase 2
100
Bologna, Meldola, Prato, Rozzano, Aviano, Roma, Candiolo, Orbassano
2021-10-29
Active, closed
AstraZeneca
Phase 3
454
Milan, Monza, Orbassano, Parma, Roma, Verona
2021-10-28
Active, closed
AstraZeneca
Phase 3
927
Bologna, Candiolo, Livorno, Milan, Naples, Negrar, Padova, Roma
2021-10-25
Recruiting
Bayer
Phase 1/2
400
Aviano, Milan, Orbassano, Parma, Roma, Rozzano, Verona
2021-10-25
Recruiting
AstraZeneca
Phase 1/2
460
Milan, Modena, Roma
2021-10-18
Active, closed
Janssen Research & Development, LLC
Phase 3
587
Bari, Bergamo, Bologna, Florence, Meldola, Pavia, Roma, Turin
2021-10-14
Recruiting
Solid Tumors in RASopathies
NCT05761314RASopathy, Costello Syndrome, Cardio-Facio-Cutaneous Syndrome, Noonan Syndrome
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not applicable
100
Roma
2021-10-12
Active, closed
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
NCT04971226Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
DrugsBosutinib·Asciminib·ABL001·Nilotinib
Novartis Pharmaceuticals
Phase 3
405
Bologna, Milan, Reggio Emilia, Roma, Verona
2021-10-06
Active, closed
Novartis Pharmaceuticals
Phase 3
129
Roma, Naples
2021-10-05
Recruiting
Pfizer
Phase 3
893
Meldola, Milan, Monza, Catania, Bologna, Genova, Roma
2021-10-04
Active, closed
Study of INBRX-109 in Conventional Chondrosarcoma
NCT04950075Conventional Chondrosarcoma
DrugINBRX-109
Inhibrx Biosciences, Inc
Phase 2
206
Bologna, Candiolo, Milan, Palermo, Prato, Roma
2021-09-23
Active, closed
A Non-interventional Cohort Safety Study of Patients With hATTR-PN
NCT04850105Hereditary Transthyretin Amyloidosis With Polyneuropthy
Akcea Therapeutics
Observational
202
Roma, Bologna, Genova, Messina, Milan, Naples, Pavia
2021-09-21
Active, closed
Bristol-Myers Squibb
Phase 3
338
Catania, Pavia, Perugia, Roma
2021-09-15
Recruiting
Italian Sarcoma Group
Phase 2
16
Prato, Roma, Candiolo, Bologna, Milan, Palermo
2021-09-14
Recruiting
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
NCT05006716B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma, Non-Hodgkin Lymphoma
DrugTacabrutideg
BeOne Medicines
Phase 1/2
689
Bologna, Milan, Roma, Verona
2021-09-13
Active, closed
AstraZeneca
Phase 3
98
Florence, Meldola, Messina, Naples, Padova, Roma, Terni, Verona
2021-09-12
Recruiting
Amgen
Phase 3
60
Chieti, Genova, Milan, Roma
2021-09-09
Recruiting
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
NCT05059444Bladder Carcinoma, Ureter Carcinoma, Renal Pelvis Carcinoma, Non-small Cell Lung Cancer
Guardant Health, Inc.
Observational
2,285
Meldola, Reggio Emilia, Roma
2021-09-07
Active, closed
Nuvation Bio Inc.
Phase 2
217
Bari, Catania, Milan, Monserrato, Naples, Roma
2021-09-01
Active, closed
Janssen Research & Development, LLC
Phase 4
411
Ancona, Monserrato, Reggio Emilia, Roma, Rozzano (MI), Verona
2021-08-30
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Avellino, Naples, Bologna, Meldola, Reggio Emilia, Roma, Milan, Rozzano (MI)
2021-08-27
Active, closed
Sophia Genetics SAS
Observational
4,000
Parma, Roma, Udine
2021-08-21
Active, closed
Inventiva Pharma
Phase 3
1,000
San Giovanni Rotondo, Milan, Naples, Palermo, Roma, Bologna, Novara, Torino
2021-08-19
Active, closed
Pfizer
Phase 3
118
Bergamo, Naples, Roma, Bologna
2021-08-12
Recruiting
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
NCT05003986Focal Segmental Glomerulosclerosis, Minimal Change Disease, Immunoglobulin A Nephropathy, IgA Vasculitis
DrugSparsentan
Travere Therapeutics, Inc.
Phase 2
67
Bari, Genova, Milan, Padova, Roma
2021-08-12
Active, closed
HUYABIO International, LLC.
Phase 3
450
Milan, Perugia, Bari, Bologna, Misterbianco, Naples, Palermo, Roma
2021-08-12
Active, closed
Tanabe Pharma America, Inc.
Phase 3
286
Roma, Brescia BS, Cuneo CN, Genova GE, Milan, Modena, Trieste TS
2021-08-10
Active, closed
AstraZeneca
Phase 3
712
Bari, Florence, Meldola, Milan, Padova, Pozzuoli, Reggio Emilia, Roma
2021-08-05
Active, closed
MedSIR
Phase 2
393
Bologna, Milan, Monza, Parma, Piacenza, Roma
2021-08-05
Active, closed
Octapharma
Phase 3
50
Naples, Roma, Treviso
2021-08-04
Recruiting
Novartis Pharmaceuticals
Phase 3
98
Ranica, Milan, Roma
2021-07-28
Active, closed
Novartis Pharmaceuticals
Phase 3
208
Ascoli Piceno, Avellino, Florence, Milan, Roma, Torino, Bassano del Grappa
2021-07-27
Active, closed
Biogen
Phase 3
562
Rozzano, Scafati, Brescia, Padova, Pisa, Roma
2021-07-16
Recruiting
Janssen Research & Development, LLC
Phase 3
199
Catania, Cefalù, Milan, Naples, Pavia, Roma
2021-07-15
Active, closed
Bristol-Myers Squibb
Phase 3
729
Florence, Potenza, Roma
2021-07-15
Active, closed
A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases
NCT04554914Epstein-Barr Virus (EBV)-Associated Diseases, EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD), EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD), EBV+ Posttransplant Lymphoproliferative Disease in Central Nervous System (EBV+ CNS PTLD)
DrugTabelecleucel
Pierre Fabre Medicament
Phase 2
190
Pisa, Roma, Torino
2021-07-14
Active, closed
Neurocrine Biosciences
Phase 3
103
Bologna, Milan, Naples, Roma
2021-06-25
Active, closed
Swiss Cancer Institute
Phase 2
260
Bergamo, Novara, Roma
2021-06-25
Recruiting
Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse
Observational
250
Roma
2021-06-23
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
520
Bologna, Milan, Pisa, Roma
2021-06-15
Recruiting
Genome Analysis of Human Endogenous Retroviruses (HERVs)(COVID19)
NCT06775457SARS CoV-2, Kawasaki Disease, Retrovirus Infection
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
120
Carpi, Bologna, Modena, Roma, Torino
2021-06-10
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
54
Milan, Roma
2021-06-01
Active, closed
Proprioceptive Exercise in Parkinson's Disease
NCT07681609Proprioceptive Training, Physiotherapy
I.R.C.C.S. Fondazione Santa Lucia
Not applicable
24
Roma
2021-05-31
Recruiting
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
NCT04895709Cervical Cancer, Gastric/Gastroesophageal Junction Adenocarcinoma, Microsatellite Stable Colorectal Cancer, Non-Small-Cell Lung Cancer
DrugsImzokitug·Pumitamig·Docetaxel·Nivolumab
Bristol-Myers Squibb
Phase 1/2
1,109
Rozzano, Candiolo, Milan, Naples, Roma, Siena
2021-05-27
Recruiting
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
NCT04844606Ulcerative Colitis, Ulcerative Colitis Chronic, Inflammatory Bowel Diseases, Crohn's Disease
DrugMirikizumab
Eli Lilly and Company
Phase 3
150
Bergamo, Bologna, Florence, Milan, Roma, Rome
2021-05-26
Recruiting
Poor Grade Aneurysmal Subarachnoid Hemorrhage Study Group
NCT04945603Subarachnoid Hemorrhage, Aneurysmal, Poor Grade Subarachnoid Hemorrhage
IRCCS San Raffaele
Observational
800
Bergamo, Bologna, Brescia, Lecce, Milan, Novara, Parma, Roma
2021-05-25
Active, closed
Bristol-Myers Squibb
Phase 3
681
Cremona, Florence, Meldola, Milan, Padova, Parma, Pavia, Roma
2021-05-21
Recruiting
GE Healthcare
Phase 1/2
54
Roma
2021-05-20
Recruiting
Fondazione Ricerca Traslazionale
Observational
270
Roma
2021-05-20
Recruiting
Amore Filippo
Observational
500
Roma
2021-05-20
Recruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
560
Roma
2021-05-15
Active, closed
Alfasigma S.p.A.
Observational
1,304
Bari, Brescia, Catania, Ferrara, Genova, Milan, Naples, Roma
2021-05-11
Active, closed
AstraZeneca
Phase 3
893
Bologna, Florence, Misterbianco, Naples, Padova, Prato, Roma
2021-05-10
By invitation
Cytokinetics
Phase 2/3
900
Florence, Milan, Naples, Pisa, Roma, Trieste
2021-05-06
Active, closed
Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination
NCT04868877Non-Small Cell Lung Cancer Metastatic, Gastric Cancer, Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma
DrugsBispecific·Tagrisso·Osimertinib
Merus B.V.
Phase 1/2
194
Roma, Bologna, Brescia, Milan, Orbassano, Salerno, Verona
2021-04-28
Recruiting
RECORDATI GROUP
Phase 2
12
Pisa, Roma
2021-04-28
Active, closed
Novartis Pharmaceuticals
Phase 2
236
Roma, Torino
2021-04-19
Recruiting
(Italian Migraine Registry, I-GRAINE-NEW)
NCT07163416Migraine Disorders
IRCCS San Raffaele Roma
Observational
2,030
Roma
2021-04-19
Recruiting
Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
NCT04580420Primary Hyperoxaluria Type 1, End Stage Renal Disease
DrugDcr-Phxc
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Phase 2
28
Roma
2021-04-15
Recruiting
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
NCT04728893Hematologic Malignancies, Waldenstroms Macroglobulinaemia, Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia
DrugNemtabrutinib
Merck Sharp & Dohme LLC
Phase 2
490
Bari, Bologna, Brescia, Milan, Naples, Pavia, Reggio Emilia, Roma
2021-04-05
Recruiting
Italian Sarcoma Group
Observational
300
Bologna, Milan, Rozzano, Palermo, Aviano, Prato, Roma, Candiolo
2021-04-02
Active, closed
Novo Nordisk A/S
Phase 3
1,205
Catanzaro, San Giovanni Rotondo, Palermo, Bologna, Florence, Foggia, Milan, Roma
2021-04-01
Recruiting
Boston Scientific Corporation
Observational
12,500
Modena, Roma
2021-03-31
Active, closed
Kedrion S.p.A.
Phase 3
30
Brescia, Florence, Genova, Milan, Naples, Roma
2021-03-31
Recruiting
Guerbet
Phase 4
2,076
Siena, Trieste, Milan, Roma, Verona
2021-03-24
Active, closed
EMN Trial Office S.r.l. Impresa Sociale
Phase 2
50
Bari, Milan, Perugia, Roma, Trieste, Udine
2021-03-21
Recruiting
THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI Guided Radiotherapy
NCT04815694Neoadjuvant Chemoradiotherapy, Locally Advanced Rectal Cancer, Pathological Complete Response
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not applicable
179
Roma
2021-03-17
Active, closed
Atrasentan in Patients With Proteinuric Glomerular Diseases
NCT04573920IgA Nephropathy, Focal Segmental Glomerulosclerosis, Alport Syndrome, Diabetic Kidney Disease
DrugAtrasentan
Novartis Pharmaceuticals
Phase 2
103
Roma
2021-03-15
Active, closed
Karyopharm Therapeutics Inc
Phase 3
353
Catania, Meldola, Genova, Milan, Monza, Novara, Rionero in Vulture, Roma
2021-03-11
Recruiting
UCB Biopharma SRL
Phase 3
70
Roma
2021-03-11
Active, closed
CD19-CAR_Lenti T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and DLBCL or PML
NCT04787263Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma, Primary Mediastinal Lymphoma
Bambino Gesù Hospital and Research Institute
Phase 1/2
32
Roma
2021-03-04
Recruiting
Syndax Pharmaceuticals
Phase 2
296
Brescia, Milan, Monza, Pavia, Roma, Torino
2021-03-04
Active, closed
German CLL Study Group
Phase 3
897
Catania, Ferrara, Mestre, Milan, Perugia, Roma, Torino
2021-03-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
747
Meldola, Rozzano, Orbassano, Arezzo, Bari, Milan, Pavia, Roma
2021-02-25
Recruiting
Gruppo Italiano Malattie EMatologiche dell'Adulto
Not applicable
38
Bari, Florence, Genova, Perugia, Roma, Rozzano
2021-02-12
Active, closed
AstraZeneca
Phase 1
155
Aviano, Meldola, Orbassano, Roma
2021-02-02
Active, closed
Forma Therapeutics, Inc.
Phase 3
450
Pavia, Catania, Orbassano, Padova, Palermo, Roma
2021-01-29
Recruiting
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
NCT04031677Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
250
Aviano, Candiolo, Meldola, Milan, Padova, Roma
2021-01-20
Active, closed
Pfizer
Phase 3
257
Udine, Milan, San Sisto, Roma, Rome, Siena, Candiolo, Bari
2021-01-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
990
Roma, Rome, Milan, Candiolo, Brescia, Naples, Padova
2021-01-10
Active, closed
Amgen
Phase 1/2
181
Bergamo, Bologna, Brescia, Catania, Milan, Naples, Roma
2021-01-04
Recruiting
Medication Related Osteonecrosis of the Jaws (MRONJ) in a Cohort of Patients Treated by Antiresorptive Drugs
NCT06457776Osteonecrosis of the Jaw, Osteonecrosis Due to Drugs, Jaw, Osteonecrosis Due to Drug, Bisphosphonate-Associated Osteonecrosis
Catholic University of the Sacred Heart
Observational
126
Roma
2021-01-01
Active, closed
IRCCS San Raffaele Roma
Not applicable
70
Bologna, Ferrara, Foggia, Messina, Roma, Rome, San Giovanni Rotondo
2020-12-28
Active, closed
Daiichi Sankyo
Phase 3
605
Bologna, Catania, Genova, Milan, Orbassano, Roma
2020-12-21
Active, closed
Janssen Research & Development, LLC
Phase 2
220
Bari, Florence, Genova, Milan, Pisa, Roma, Rome, Torino
2020-12-18
Active, closed
Novartis Pharmaceuticals
Phase 2
17
Roma
2020-12-18
Active, closed
Neurocrine Biosciences
Phase 3
182
Ancona, Bologna, Florence, Messina, Milan, Naples, Padova, Roma
2020-12-16
Active, closed
Merck Sharp & Dohme LLC
Phase 3
672
Modena, Florence, Verona, Brescia, Milan, Padova, Roma
2020-12-08
Active, closed
University Hospital, Basel, Switzerland
Not applicable
64,374
Florence, Roma, Torino
2020-12-01
Recruiting
Clinical Decision Support Tool in PARDS Pilot Study
NCT04068012Ventilation Therapy; Complications, Ventilator-Induced Lung Injury, Ards
Children's Hospital Los Angeles
Not applicable
180
Roma
2020-12-01
Active, closed
Eli Lilly and Company
Phase 3
312
Milan, Roma
2020-11-25
Active, closed
Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
NCT04623541Relapsed/Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome, Treatment-naïve High Risk Chronic Lymphocytic Leukemia
DrugsEpcoritamab·Pirtobrutinib·Lenalidomide·Venetoclax
Genmab
Phase 1/2
194
Bologna, Torino, Ferrara, Meldola, Rome, Roma, Brescia, Milan
2020-11-25
Active, closed
Science Corporation
Not applicable
38
Roma
2020-11-24
Recruiting
Alnylam Pharmaceuticals
Observational
1,500
Milan, Naples, Palermo, Roma
2020-11-23
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 3
691
Bologna, Florence, Milan, Roma
2020-11-12
Active, closed
AstraZeneca
Phase 1/2
702
Milan, Modena, Naples, Padova, Roma
2020-11-12
Recruiting
Vyxeos® With Clofarabine for Pediatric AML
NCT07156435Relapsed Pediatric AML, Refractory Pediatric AML
DrugClofarabine
Princess Maxima Center for Pediatric Oncology
Phase 1
25
Monza, Roma
2020-11-06
Active, closed
Pfizer
Phase 3
114
Roma, Rome
2020-11-05
By invitation
Novo Nordisk A/S
Observational
60
Parma, Roma, Torino, Vicenza
2020-10-23
Active, closed
Janssen Research & Development, LLC
Phase 3
308
Bologna, Catania, Meldola, Milan, Monza, Ravenna, Roma, Rozzano
2020-10-13
Recruiting
QualiMed Innovative Medizinprodukte GmbH
Observational
198
Rozzano, Forlì, Pavia, Roma
2020-10-03
Active, closed
GlaxoSmithKline
Phase 3
302
Bologna, Milan, Pavia, Roma
2020-10-01
Recruiting
Mid- and Long-term Outcomes of Custom-made Aortic Devices
NCT05777460Aortic Diseases, Thoracic Aortic Aneurysm
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
60
Roma
2020-10-01
Recruiting
Smith & Nephew, Inc.
Observational
400
Acquaviva delle Fonti, Roma, Sassuolo
2020-10-01
Active, closed
argenx
Phase 2
229
Brescia, Florence, Genova, Messina, Milan, Pisa, Roma, Torino
2020-09-18
Active, closed
Regina Elena Cancer Institute
Phase 2
91
Roma, Rome
2020-09-16
Active, closed
Philogen S.p.A.
Phase 2
98
Bologna, Candiolo, Orbassano, Roma
2020-08-28
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
125
Naples, Pavia, Pisa, Roma
2020-08-25
Recruiting
Nordic Lymphoma Group
Phase 3
300
Aviano, Bari, Calabria, Monza, Naples, Roma, Segrate, Trieste
2020-08-19
Active, closed
Pfizer
Phase 3
77
Roma, Florence, Naples
2020-08-18
Active, closed
University Hospital, Basel, Switzerland
Not applicable
382
Roma, Trento
2020-07-28
Recruiting
IFOM ETS - The AIRC Institute of Molecular Oncology
Observational
1,500
Bergamo, Milan, Novara, Padova, Pavia, Roma, Reggio Emilia
2020-07-16
Recruiting
Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib
NCT03651206Ovarian Carcinosarcoma, Endometrial Carcinosarcoma
DrugNiraparib
ARCAGY/ GINECO GROUP
Phase 2/3
138
Bologna, Catania, Meldola, Milan, Naples, Roma, Torino
2020-07-15
Active, closed
GlaxoSmithKline
Phase 3
242
Milan, Modena, Monza, Naples, Negrar Verona, Padova, Palermo, Roma
2020-07-14
Active, closed
Baxalta now part of Shire
Observational
207
Milan, Roma
2020-07-09
Active, closed
Actelion
Phase 3
935
Milan, Modena, Nuoro, Pavia, Pisa, Roma
2020-06-30
Recruiting
IRCCS San Raffaele Roma
Observational
300
Roma
2020-06-15
Active, closed
Janssen Research & Development, LLC
Phase 3
419
Bologna, Milan, Roma, Turin
2020-06-12
Active, closed
AstraZeneca
Phase 2
452
Milan, Naples, Padova, Roma, Verona
2020-06-03
Active, closed
Screening for Abdominal Aortic Aneurysm and Popliteal Artery Aneurysm
NCT05360108Aortic Aneurysm, Abdominal, Popliteal Artery Aneurysm
Centre Hospitalier Universitaire Vaudois
Observational
507
Castelfranco Veneto, Padova, Roma, Rovigo
2020-06-01
Recruiting
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
NCT04256317Myelodysplastic Syndromes, Acute Myeloid Leukemia, Myelodysplastic Syndrome/Neoplasm, Chronic Myelomonocytic Leukemia
DrugsVenclexta·Azacitidine·Venetoclax
Taiho Oncology, Inc.
Phase 2/3
316
Ravenna, Florence, Torino, Bologna, Milan, Novara, Roma
2020-05-21
Active, closed
AstraZeneca
Phase 2
240
Bologna, Catanzaro, Meldola, Messina, Milan, Monza, Naples, Roma
2020-04-22
Active, closed
GlaxoSmithKline
Phase 3
325
Bologna, Brescia, Catanzaro, Milan, Pavia, Perugia, Ravenna, Roma
2020-04-02
Active, closed
BeOne Medicines
Phase 1
437
Milan, Perugia, Ravenna, Roma, Verona
2020-03-24
Recruiting
University of Oxford
Phase 3
70,000
Roma
2020-03-19
Recruiting
Fondazione Policlinico Universitario Campus Bio-Medico
Not applicable
132
Roma
2020-03-12
Recruiting
Endoscopic Management of Non-anastomotic Biliary Strictures Following Liver Transplantation.
NCT05761483Liver Transplant Disorder, Ischemic Cholangiopathy, Non-anastomotic Biliary Stricture, Biliary Stricture
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
40
Roma
2020-03-12
Active, closed
UMC Utrecht
Not applicable
216
Bologna, Roma
2020-03-10
Recruiting
Mi-RNA and COVID-19
NCT06881160COVID-19
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
49
Roma
2020-03-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
6,033
Rome, Padova, Bari, Catania, Roma
2020-02-27
Active, closed
Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi
NCT04042025Spinal Muscular Atrophy Type I, Spinal Muscular Atrophy Type II, Spinal Muscular Atrophy Type III, SMA
DrugsOnasemnogene Abeparvovec-xioi·Zolgensma
Novartis Gene Therapies
Phase 3
85
Roma, Genova, Milan
2020-02-10
Active, closed
NTRK 1,2,3 Rearrangements in Patients With Solid Tumors
NCT06780384NTRK1/2/3 Fusion Gene Detection
Federico Cappuzzo
Observational
5,000
Roma
2020-02-05
Recruiting
Eli Lilly and Company
Phase 2
105
Bologna, Candiolo, Milan, Padova, Roma, Rozzano
2020-01-22
Active, closed
BeOne Medicines
Phase 3
955
Bologna, Meldola, Milan, Modena, Novara, Ravenna, Roma, Terni
2020-01-16
Active, closed
Actelion
Phase 3
138
Bologna, Milan, Padova, Roma, S. Donato Milanese, Torino
2020-01-16
Active, closed
Advanced Accelerator Applications
Phase 3
226
Bologna, Genova, Meldola, Milan, Naples, Reggio Emilia, Roma
2020-01-08
Active, closed
Institut de Recherches Internationales Servier
Phase 3
331
Turin, Bologna, Padua, Roma, Rozzano
2020-01-05
Recruiting
FATAL-NSTI Study (Factors Associated With In-hospital mortALity in NSTI).
NCT07359651Necrotizing Fascitis, Fournier Gangrene, Fournier's Gangrene, Soft Tissue Infections
University of Cagliari
Observational
300
Cagliari, Milan, Monza, Roma
2020-01-01
Active, closed
The Netherlands Cancer Institute
Phase 3
538
Bologna, Roma
2020-01-01
Recruiting
International Multicenter Mycotic Aneurysm Aorto-iliac Study
NCT05777447Mycotic Aneurysm, Aortic Diseases
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
40
Roma
2020-01-01
Active, closed
Galderma R&D
Phase 3
1,700
Bologna, L’Aquila, Roma, Rome, Rozzano, Vicenza
2019-12-30
Active, closed
University of Roma La Sapienza
Observational
138
Padova, Roma, Verona
2019-12-20
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
450
Florence, Milan, Roma
2019-12-19
Recruiting
Merck Sharp & Dohme LLC
Observational
1,065
Florence, Milan, Roma
2019-12-19
Active, closed
Cold Agglutinin Disease Real World Evidence Registry
NCT05791708Cold Agglutinin Disease (CAD), Cold Agglutinin Syndrome (CAS)
RECORDATI GROUP
Observational
429
Brescia, Campobasso, Novara, Palermo, Pavia, Ravenna, Reggio Calabria, Roma
2019-12-12
Active, closed
LAM561 With RT and TMZ for Adults With Glioblastoma
NCT04250922Primary Glioblastoma, Glioblastoma Multiforme
DrugLAM561
Laminar Pharmaceuticals
Phase 2/3
144
Padova, Milan, Roma, Turin
2019-12-01
Active, closed
An Integrated Genomic Approach to Assess Genetic Risk and Drug Sensitivity
NCT07555639Colon Cancer, Breast Cancer, Ovarian Cancer, Genetic Risk Factors
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not applicable
4,000
Roma
2019-11-21
Active, closed
Gilead Sciences
Phase 2/3
72
Bergamo, Brescia, Milan, Roma, Rome
2019-11-21
Active, closed
ETOP IBCSG Partners Foundation
Phase 2
96
Padova, Roma
2019-11-19
Active, closed
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors
NCT04082429Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors
DrugConcizumab
Novo Nordisk A/S
Phase 3
156
Florence, Milan, Roma, Torino
2019-11-13
Recruiting
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
NCT04065399Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Mixed Lineage Acute Leukemia, Mixed Phenotype Acute Leukemia
DrugsCobicistat·Revumenib
Syndax Pharmaceuticals
Phase 1/2
447
Bologna, Meldola, Milan, Roma, Vicenza
2019-11-05
Active, closed
Pediatric Long-Term Follow-up and Rollover Study
NCT03975829Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma, Oligodendroglioma, Childhood
DrugsDabrafenib·Trametinib
Novartis Pharmaceuticals
Phase 4
163
Florence, Genova, Milan, Roma, Torino
2019-11-04
Active, closed
AstraZeneca
Phase 3
140
Cuneo, Florence, Milan, Naples, Roma, Torino
2019-10-29
Recruiting
GlaxoSmithKline
Phase 1/2
184
Genova, Milan, Padova, Roma, Torino
2019-10-25
Active, closed
Niguarda Hospital
Phase 2
28
Alessandria, Bergamo, Bologna, Brescia, Milan, Novara, Pavia, Roma
2019-10-04
Recruiting
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
NCT03955445C3 Glomerulopathy, Immune-complex-membranoproliferative Glomerulonephritis
DrugIptacopan
Novartis Pharmaceuticals
Phase 3
225
Bari, Ranica, Roma
2019-10-03
Recruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
200
Roma
2019-10-01
Active, closed
NeuroDerm Ltd.
Phase 3
381
Arcugnano, Cassino, Chieti, Grosseto, Milan, Naples, Pavia, Roma
2019-09-30
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Bologna, Milan, Negrar, Padova, Palermo, Rho, Roma, Rozzano
2019-09-26
By invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT03683186PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension
United Therapeutics
Phase 3
1,000
Palermo, Foggia, Genova, Milan, Monza, Pavia, Roma
2019-09-23
Recruiting
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
NCT04104776Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Lymphoma, T-Cell, Mesothelioma, Malignant
DrugsTulmimetostat·Enzalutamide
Novartis Pharmaceuticals
Phase 1/2
300
Bologna, Milan, Roma, Rozzano
2019-09-18
Active, closed
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
NCT04067336Advanced Malignant Neoplasm, Acute Myeloid Leukemia, Mixed Lineage Leukemia, Mixed Lineage Acute Leukemia
DrugsZiftomenib·Itraconazole·Midazolam
Kura Oncology, Inc.
Phase 1/2
263
Bologna, Meldola, Ravenna, Roma
2019-09-12
Recruiting
PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies
NCT04371042NAFLD - Nonalcoholic Fatty Liver Disease, Diabetes, Obesity, Metabolic Syndrome
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
5,000
Roma
2019-09-01
Recruiting
Biomarkers and Unstable Carotid Plaque
NCT06887894Carotid Artery Diseases
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
200
Roma
2019-09-01
Recruiting
Centro di Riferimento Oncologico - Aviano
Observational
78
Aviano, Genova, Messina, Milan, Modena, Naples, Reggio Emilia, Roma
2019-08-27
Active, closed
Janssen Research & Development, LLC
Phase 2/3
118
Ascoli Piceno, Brescia, Catania, Florence, Milan, Monza, Novara, Roma
2019-08-15
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
Meldola, Rozzano, Roma, Bari, Bergamo, Candiolo, Catania, Genova
2019-08-09
Active, closed
Bristol-Myers Squibb
Phase 3
839
Catania, Genova, Milan, Naples, Padova, Roma
2019-08-05
Active, closed
Merck Sharp & Dohme LLC
Phase 3
595
Roma, Orbassano, Vicenza, Arezzo, Catania, Milan, Naples, Pavia
2019-07-24
Active, closed
Amgen
Phase 3
457
Milan, Palermo, Pavia, Roma
2019-07-19
Recruiting
University of Milano Bicocca
Observational
7,000
Baggiovara, Bologna, Bolzano, Carate Brianza, Ferrara, Florence, Genova, Roma
2019-07-15
Active, closed
Long Term Extension Study in Patients With Primary Hyperoxaluria
NCT04042402Primary Hyperoxaluria Type 1 (PH1), Primary Hyperoxaluria Type 2 (PH2), Kidney Diseases, Urologic Diseases
DrugDcr-Phxc
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Phase 3
75
Roma
2019-07-09
Active, closed
Novo Nordisk A/S
Phase 2
62
Florence, Genova, Milan, Roma
2019-07-04
Active, closed
Novartis Pharmaceuticals
Phase 2
121
Roma
2019-06-24
Active, closed
Bristol-Myers Squibb
Phase 3
437
Brescia, Arezzo, Aviano (PN), Milan, Parma, Roma
2019-06-21
Active, closed
DIAbetes and NAFLD
NCT06315361NAFLD, Diabetes, NASH, Fibrosis, Liver
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
600
Roma
2019-05-20
Active, closed
Inspiris Resilia Durability Registry
NCT03666741Aortic Valve Stenosis
Institut für Pharmakologie und Präventive Medizin
Observational
400
Florence, Milan, Roma, Salerno
2019-04-26
Active, closed
AstraZeneca
Phase 3
810
Faenza, Florence, Milan, Naples, Roma, Verona
2019-04-16
Active, closed
Madrigal Pharmaceuticals, Inc.
Phase 3
1,759
Messina, Milan, Novara, Palermo, Roma, Bergamo, Florence, Pisa
2019-03-28
Active, closed
Avelumab Program Rollover Study
NCT03815643Solid Tumors
DrugAvelumab
EMD Serono Research & Development Institute, Inc.
Phase 3
205
Naples, Padova, Roma, Rozzano
2019-03-22
Active, closed
Institut de Recherches Internationales Servier
Phase 3
856
Cagliari, Cremona, Naples, Padova, Pisa, Potenza, Reggio Emilia, Roma
2019-03-21
Recruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
10
Roma
2019-03-14
Active, closed
Novartis Pharmaceuticals
Phase 2
22
Pavia, Roma, Torino, Naples
2019-03-13
Active, closed
AstraZeneca
Phase 3
724
Florence, Genova, Milan, Orbassano, Padova, Pavia, Roma, Rozzano
2019-03-06
Active, closed
University Hospital, Montpellier
Phase 2/3
113
Roma
2019-02-18
Active, closed
Xenon Pharmaceuticals Inc.
Phase 2
325
Bologna, Catanzaro, Milan, Pavia, Pisa, Reggio Calabria, Roma
2019-01-30
Active, closed
Janssen Research & Development, LLC
Phase 3
765
Faenza, Milan, Naples, Padova, Parma, Perugia, Pisa, Roma
2019-01-25
Active, closed
Celgene
Phase 3
363
Orbassano, Bologna, Florence, Meldola, Milan, Padova, Reggio Calabria, Roma
2019-01-02
Active, closed
The European Robotic Spinal Instrumentation (EUROSPIN) Study
NCT03398915Degenerative Disc Disease, Spondylolisthesis, Spinal Stenosis, Recurrent Disc Herniation
Marc Schröder
Observational
932
Cesena, Ferrara, Messina, Roma
2019-01-01
Recruiting
The Management of Asymptomatic Carotid Stenosis
NCT06882954Carotid Artery Diseases, Carotid Stenosis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
500
Roma
2019-01-01
Recruiting
Genomic Profiles Analysis in Children, Adolescents and Young Adult With Sarcomas
NCT04621201Diagnosed or Relapsed/Refractory Sarcomas
Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna
Observational
120
Torino, Bologna, Florence, Genova, Milan, Pavia, Roma, Trieste
2018-12-06
Active, closed
AstraZeneca
Phase 3
825
Ancona, Bari, Bergamo, Florence, Milan, Monza, Padova, Roma
2018-12-06
Recruiting
Pulmonary Hemodynamics During Exercise - Research Network
NCT03954574Pulmonary Circulation Diseases
Medical University of Graz
Observational
1,500
Bologna, Roma
2018-12-01
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
58
Ancona, Bologna, Brescia, Roma, Torino
2018-11-19
Active, closed
IRCCS San Raffaele
Observational
200
Lecco, Milan, Modena, Roma, Florence, Sassari, Verona
2018-10-30
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
271
Bergamo, Naples, Padova, Roma, Siena, Turin, Udine
2018-10-30
Active, closed
Janssen Research & Development, LLC
Phase 3
84
Bologna, Florence, Messina, Roma, San Giovanni Rotondo, Trieste
2018-10-29
Active, closed
AstraZeneca
Phase 3
730
Brescia, Milan, Orbassano, Parma, Roma, Rozzano, Terni
2018-09-27
Active, closed
AstraZeneca
Phase 3
1,246
Arezzo, Milan, Naples, Orbassano, Parma, Pavia, Roma, Terni
2018-09-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
976
Meldola, Bari, Bergamo, Genova, Milan, Naples, Padova, Roma
2018-09-12
Recruiting
Celgene
Phase 2/3
1,541
Ancona, Bologna, Milan, Monza, Naples, Roma, Rome, Rozzano (MI)
2018-07-19
Active, closed
Eli Lilly and Company
Phase 3
1,058
Catanzaro, Genova, Pisa, Rho, Roma, Rome, Rozzano, Torino
2018-07-18
Active, closed
Exelixis
Phase 3
837
Tricase, Rozzano, Bologna, Brescia, Milan, Naples, Novara, Roma
2018-06-10
Recruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not applicable
76
Roma
2018-06-01
Active, closed
pharmaand GmbH
Phase 3
1,097
Aviano, Candiolo, Catania, Chieti, Naples, Roma, Vicenza
2018-05-14
Active, closed
Biotronik SE & Co. KG
Observational
3,030
Milan, Roma
2018-05-14
Active, closed
MedImmune LLC
Phase 1
400
Meldola, Naples, Ravenna, Roma
2018-04-24
Active, closed
Pyruvate Kinase Deficiency Global Longitudinal Registry
NCT03481738Pyruvate Kinase Deficiency
Agios Pharmaceuticals, Inc.
Observational
500
Pescara, Naples, Genoa, Milan, Roma
2018-04-23
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,409
Bologna, Cagliari, Cento, Messina, Milan, Padova, Roma, Rome
2018-04-13
Active, closed
Merck Sharp & Dohme LLC
Phase 2
340
Roma, Aviano, Naples, Torino
2018-04-09
Active, closed
Eli Lilly and Company
Phase 3
533
Milan, Roma
2018-03-14
Recruiting
Randomization of Single vs Multiple Arterial Grafts
NCT03217006Coronary Artery Disease, Heart Diseases
Weill Medical College of Cornell University
Not applicable
4,300
Bari, Brescia, Cotignola, Roma, Rome, Torino
2018-01-07
Active, closed
Bambino Gesù Hospital and Research Institute
Phase 1/2
42
Roma
2018-01-05
Recruiting
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
NCT03142152Functional Mitral Regurgitation, Heart Failure, Mitral Valve Insufficiency, Heart Diseases
Cardiac Dimensions, Inc.
Not applicable
300
Naples, Roma
2018-01-01
Recruiting
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
NCT03394365Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, Lymphoproliferative Disorders, Allogeneic Hematopoietic Cell Transplant
DrugTabelecleucel
Pierre Fabre Medicament
Phase 3
115
Milan, Pavia, Roma, Torino
2017-12-29
Recruiting
Registry for Patients With Lipodystrophy
NCT03553420Lipodystrophy Acquired, Lipodystrophy Congenital
University of Ulm
Observational
5,000
Bologna, Milan, Novara, Palermo, Pisa, Roma
2017-12-16
Active, closed
Alimentiv Inc.
Phase 4
334
San Donato Milanese, Milan, Roma, Castellana Grotte, Catania, Padova
2017-11-20
Active, closed
BeiGene
Phase 3
590
Brescia, Meldola, Milan, Modena, Ravenna, Roma, Terni, Torino
2017-10-31
Active, closed
Endurant CHevAr New Indication Trial: ENCHANT
NCT03320252AAA - Abdominal Aortic Aneurysm
Medtronic Cardiovascular
Observational
150
Cosenza, La Spezia, Roma
2017-10-26
Recruiting
Italfarmaco
Phase 2/3
206
Genova, Messina, Milan, Roma
2017-10-24
Active, closed
AstraZeneca
Phase 3
1,324
Benevento, Meldola, Milan, Naples, Perugia, Pisa, Roma, Rozzano
2017-10-11
Active, closed
Takeda
Phase 1/2
59
Florence, Pavia, Roma, Torino
2017-09-06
Active, closed
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
NCT03170960Urothelial Carcinoma, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Castration-resistant Prostate Cancer
DrugsCabozantinib·Tecentriq·Atezolizumab
Exelixis
Phase 1
914
Meldola, Rozzano, Milan, Naples, Pavia, Roma
2017-09-05
Recruiting
Charite University, Berlin, Germany
Phase 2
250
Roma
2017-09-01
Active, closed
Novartis Pharmaceuticals
Phase 3
206
Bari, Bologna, Pavia, Roma, Siena
2017-08-23
Active, closed
Murdoch Childrens Research Institute
Phase 3
450
Alessandria, Bologna, Florence, Genova, Milan, Pisa, Roma
2017-08-10
Active, closed
Savolitinib vs. Sunitinib in MET-driven PRCC.
NCT03091192Carcinoma, Carcinoma, Renal Cell, Kidney Neoplasms, Urologic Neoplasms
DrugsSavolitinib·Sunitinib
AstraZeneca
Phase 3
60
Arezzo, Meldola, Milan, Modena, Orbassano, Pavia, Roma
2017-07-25
Recruiting
Biology of Juvenile Myoclonic Epilepsy
NCT03400371Juvenile Myoclonic Epilepsy
King's College London
Observational
1,000
Roma
2017-07-13
Active, closed
Ten Year Implant Survivorship of the ANTHEM™ PS Total Knee System
NCT03078543Arthroplasty, Replacement, Knee
Smith & Nephew, Inc.
Observational
148
Milan, Roma
2017-06-28
Active, closed
Pfizer
Phase 3
296
Catania, Monza, Milan, Rozzano, Perugia, Pordenone, Parma, Roma
2017-04-27
Active, closed
AstraZeneca
Phase 3
987
Bergamo, Meldola, Milan, Palermo, Roma, Terni
2017-03-27
Recruiting
Turning Point Therapeutics, Inc.
Phase 1/2
500
Milan, Palermo, Pordenone, Ravenna, Reggio Emilia, Roma, Terni
2017-03-07
Active, closed
Astellas Pharma Global Development, Inc.
Phase 2
900
Faenza (RA), Arezzo, Candiolo, Cremona, Forlì, Roma, Toscana, Trento
2016-12-22
Active, closed
ViiV Healthcare
Phase 3
631
Brescia, Milan, Monza MB, Roma
2016-10-27
Recruiting
MEASuRE: Metreleptin Effectiveness And Safety Registry
NCT02325674Generalised Lipodystrophy, Partial Lipodystrophy
DrugMetreleptin
Chiesi Farmaceutici S.p.A.
Observational
100
Bologna, Pisa, Roma, Novara
2016-10-11
Active, closed
Eli Lilly and Company
Phase 2
234
Roma, Negrar, Bologna, Naples
2016-09-14
Active, closed
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
NCT02864992Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV
DrugTepotinib
EMD Serono Research & Development Institute, Inc.
Phase 2
337
Genova, Milan, Naples, Padova, Roma, Rozzano
2016-09-13
Active, closed
Celgene
Phase 1/2
130
Bologna, Emilia-Romagna, Florence, Genova, Orbassano, Padova, Pesaro, Roma
2016-06-03
Recruiting
Quality of Pediatric Resuscitation in a Multicenter Collaborative
NCT02708134Cardiac Arrest, Cardiopulmonary Arrest
Children's Hospital of Philadelphia
Observational
7,000
Roma
2016-05-02
Active, closed
Tesaro, Inc.
Phase 1
729
Milan, Modena, Naples, Roma, Verona
2016-03-07
Recruiting
The Oxford Risk Factors And Non-Invasive Imaging Study
NCT05169333Cardiovascular Diseases, Cardiovascular Risk Factors
University of Oxford
Observational
250,000
Milan, Roma
2016-02-23
Active, closed
Geron Corporation
Phase 2/3
289
Milan, Rozzano, Rionero in Vulture, Roma, Ancona, Bologna, Florence, Reggio Calabria
2016-01-12
Recruiting
University of Siena
Observational
370
Chioggia, Padova, Roma, Siena
2015-12
Active, closed
AstraZeneca
Phase 3
1,126
Arezzo, Meldola, Milan, Naples, Orbassano, Pavia, Roma, San Giovanni Rotondo
2015-11-02
Recruiting
CAR-T Long Term Follow Up (LTFU) Study
NCT02445222Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
Novartis Pharmaceuticals
Phase 3
1,105
Bologna, Monza, Milan, Rozzano, Roma
2015-11-02
Active, closed
MedImmune LLC
Phase 2
433
Benevento, Milan, Roma
2015-10-19
Active, closed
Medtronic
Observational
3,100
Bari, Bologna, Brescia, Cotignola, Milan, Pisa, Roma
2015-07
Active, closed
Exelixis
Phase 4
247
Catania, Roma, Siena, Pisa, Milan, Padua, Torino
2015-02-25
Active, closed
ViiV Healthcare
Phase 3
371
Milan, Modena, Monza MB, Roma, Torino
2015-02-23
Active, closed
A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)
NCT02912949Solid Tumours Harboring NRG1 Fusion, NSCLC Harboring NRG1 Fusion, Pancreatic Cancer Harboring NRG1 Fusion, NRG1 Fusion
DrugBispecific
Partner Therapeutics, Inc.
Phase 2
250
Milan, Roma
2015-01
Active, closed
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
NCT02319837Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
DrugsLupron·Eligard·Leuprorelin·Xtandi
Pfizer
Phase 3
1,068
Roma, Cremona, Faenza RA, Lugo RA, Meldola (FC), Naples, Orbassano (TO), Ravenna
2014-12-17
Active, closed
UNICANCER
Phase 3
1,173
Meldola, Roma
2013-11-13
Active, closed
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
DrugIbrutinib
Janssen Research & Development, LLC
Phase 3
539
Milan, Roma, Torino
2013-09-09
Active, closed
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
NCT01874353Platinum Sensitive, BRCA Mutated, Relapsed Ovarian Cancer, Following Complete or Partial Response to Platinum Based Chemotherapy
DrugOlaparib
AstraZeneca
Phase 3
327
Milan, Modena, Naples, Padova, Roma
2013-09-03
Active, closed
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
NCT01844986Newly Diagnosed, Advanced Ovarian Cancer, FIGO Stage III-IV, BRCA Mutation
DrugOlaparib
AstraZeneca
Phase 3
450
Bari, Catania, Milan, Naples, Padova, Roma
2013-08-26
Active, closed
Novartis Pharmaceuticals
Phase 3
240
Bari, Montichiari, Catania, Milan, Cefalù, Roma, Gallarate
2013-07-26
Recruiting
Javier P. Gisbert
Observational
10,000
Roma
2013-06
Recruiting
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
NCT01522183Atypical Hemolytic-Uremic Syndrome
Alexion Pharmaceuticals, Inc.
Observational
3,000
Bari, Florence, Genova, Milan, Roma, Torino
2013-03-18
Recruiting
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
NCT02493478Failed or Difficult Intubation, Sequela, Intubation; Difficult, Intubation Complication
Children's Hospital of Philadelphia
Observational
150,000
Roma
2010-03
Recruiting
Thyroid Function and Structure in Klinefelter Syndrome
NCT05581147Klinefelter Syndrome, Thyroiditis, Autoimmune, Hypothyroidism
University of Roma La Sapienza
Observational
600
Roma
2007-05-11
Rows per page Showing 1001–1272 of 1272
Previous 1 2 3
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/roma?page=3

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,272 of those studies with a site in Roma.

How many clinical trials are recruiting in Roma?

717 of the 1,272 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 94 have not yet opened recruitment, 435 are active but closed to new participants, and 26 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.